Avenue Therapeutics, Inc. (ATXI)
OTCMKTS · Delayed Price · Currency is USD
0.5200
0.00 (0.00%)
Sep 2, 2026, 9:48 AM EST
Avenue Therapeutics Market Cap
Avenue Therapeutics has a market cap or net worth of $1.71 million as of September 2, 2026. Its market cap has decreased by -5.58% in one year.
Market Cap
1.71M
Enterprise Value
-228.62K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.52
ChartMarket Cap Chart
Since June 27, 2017, Avenue Therapeutics's market cap has decreased from 27.57M to 1.71M, a decrease of -93.78%. That is a compound annual growth rate of -26.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 1.71M | -20.88% |
| Dec 31, 2025 | 2.17M | -47.28% |
| Dec 31, 2024 | 4.11M | 92.60% |
| Dec 29, 2023 | 2.13M | -61.53% |
| Dec 30, 2022 | 5.54M | -70.79% |
| Dec 31, 2021 | 18.98M | -80.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| VitaSpring Biomedical | 2.30M |
| Protagenic Therapeutics | 2.17M |
| Abpro Holdings | 1.44M |
| AXIM Biotechnologies | 1.42M |
| Sirona Biochem | 1.35M |
| Bio-Path Holdings | 1.31M |
| NKGen Biotech | 1.31M |
| Regenerative Medical Technology Group | 1.18M |